Profile
Ulrich Elben served as Chief Executive Officer at Axxima Pharmaceuticals AG and as VP-Strategic Development Operations at Vertex Pharmaceuticals, Inc. He also worked as Deputy Head-Project Management at Sanofi-Aventis U.S.
LLC and as Chief Development Officer at Avaant Pharmaceuticals, Inc. From 2015 to 2017, he was Vice President-Preclinical Operations at Anavex Life Sciences Corp.
Dr. Elben holds a doctorate degree from the University of Bonn.
Former positions of Ulrich Elben
| Companies | Position | End |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Corporate Officer/Principal | 31/05/2017 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Axxima Pharmaceuticals AG
 Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany. | Chief Executive Officer | - |
| Avaant Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Training of Ulrich Elben
| University of Bonn | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ANAVEX LIFE SCIENCES CORP. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 3 |
|---|---|
| Avaant Pharmaceuticals, Inc. | |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany. | Commercial Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Ulrich Elben
